SkinBioTherapeutics (GB:SBTX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
SkinBioTherapeutics, a life science company, has issued 2,349,624 new ordinary shares, boosting its total to 228,435,909 shares, as it prepares for trading on the AIM Market of the London Stock Exchange. This move reflects the company’s ongoing efforts to expand its investment base and strengthen its position in the skin health sector.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
